𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Evaluation of drug transporters' significance for multidrug resistance in head and neck squamous cell carcinoma

✍ Scribed by Dirk Theile; Nahal Ketabi-Kiyanvash; Christel Herold-Mende; Gerhardt Dyckhoff; Thomas Efferth; Vincent Bertholet; Walter Emil Haefeli; Johanna Weiss

Publisher
John Wiley and Sons
Year
2010
Tongue
English
Weight
462 KB
Volume
33
Category
Article
ISSN
1043-3074

No coin nor oath required. For personal study only.

✦ Synopsis

Abstract

Background.

Multidrug resistance (MDR) hampers chemotherapy in head and neck squamous cell carcinoma (HNSCC). There is little information about MDR mediating drug transporters in HNSCC.

Methods.

Nine HNSCC cell lines were characterized concerning drug transporter expression and susceptibility to cisplatin, paclitaxel, and 5‐fluorouracil (5‐FU) using a DNA microarray and proliferation assays. Three cells lines were precisely investigated for transporter expression using reverse transcriptase‐polymerase chain reaction (RT‐PCR) and drug resistance before and after simulated chemotherapies.

Results.

The cell lines differed in drug resistance and transporter expression. Cisplatin and paclitaxel resistances were inversely associated. Drugs rendered HNSCC cells resistant, cross‐resistant, or cross‐sensitive. Sensitivity changes were accompanied by transporter mRNA expression changes.

Conclusion.

Paclitaxel was identified as a potent inducer of numerous drug transporters and phenotypic MDR in HNSCC. Thus, cytostatic susceptibility of HNSCC cannot exclusively be deduced from the expression of single transporters but more likely of the entire transportome and non‐transporter modulators. © 2010 Wiley Periodicals, Inc. Head Neck, 2011

📜 SIMILAR VOLUMES

MicroRNA expression profiles of head and
MicroRNA expression profiles of head and neck squamous cell carcinoma with docetaxel-induced multidrug resistance
✍ Yuemeng Dai; Cheng-hui Xie; John P. Neis; Chun-Yang Fan; Emre Vural; Paul M. Spr 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 220 KB 👁 2 views

## Abstract ## Background The purpose of this study was to investigate the potential role of variable microRNA (miRNA) expression in the development of multidrug resistance (MDR) in head and neck cancer. ## Methods Head and neck squamous cell carcinoma cell lines UMSCC‐1 and SQ20B were treated w

Identification of cisplatin-resistance r
Identification of cisplatin-resistance related genes in head and neck squamous cell carcinoma
✍ Yukio Yamano; Katsuhiro Uzawa; Kengo Saito; Dai Nakashima; Atsushi Kasamatsu; Hi 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 French ⚖ 355 KB 👁 2 views

## Abstract Resistance to cisplatin is a major obstacle to successful treatment of head and neck squamous cell carcinoma (HNSCC). To investigate the molecular mechanism of this resistance, we compared the gene expression profiles between the cisplatin‐sensitive SCC cell lines (Sa‐3, H‐1 and KB) and

Evaluation of university of florida spli
Evaluation of university of florida split-course technique for various head and neck squamous cell carcinomas
✍ Rodney R. Million; Roland C. Zimmermann 📂 Article 📅 1975 🏛 John Wiley and Sons 🌐 English ⚖ 269 KB 👁 2 views

A retrospective evaluation was made of 260 patients with squamous carcinoma of various head and neck sites in order to determine the relative value of continuous vs. split-course irradiation techniques. There was no obvious difference in local control or survival in early-stage cases. The continuous

Hyperphosphorylation of replication prot
Hyperphosphorylation of replication protein A in cisplatin-resistant and -sensitive head and neck squamous cell carcinoma cell lines
✍ Karoline C. Manthey; Jason G. Glanzer; Diana D. Dimitrova; Greg G. Oakley 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 419 KB 👁 3 views

## Abstract ## Background Resistance to chemotherapy is a major limitation in the treatment of head and neck squamous cell carcinomas (HNSCCs), accounting for high mortality rates in patients. Here, we investigated the role of replication protein A (RPA) in cisplatin and etoposide resistance. ##

Molecular markers of head and neck squam
Molecular markers of head and neck squamous cell carcinoma: Promising signs in need of prospective evaluation
✍ Phillipe Lothaire; Evandro de Azambuja; Didier Dequanter; Yassine Lalami; Christ 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 155 KB 👁 1 views

## Background: The aim of this article is to review recent developments in the biological understanding of head and neck squamous cell carcinomas. ## Methods and results: We describe the markers according to their function and their prognostic or predictive roles. some associations can be found b

Simultaneous combination radiotherapy an
Simultaneous combination radiotherapy and multidrug chemotherapy for stage III and stage IV squamous cell carcinoma of the head and neck
✍ Bert L. Smith; Jerry L. Franz; Joaquin G. Mira; George A. Gates; J. Sapp; A. B. 📂 Article 📅 1980 🏛 John Wiley and Sons 🌐 English ⚖ 480 KB 👁 1 views

## Abstract Combined simultaneous radiotherapy and multidrug chemotherapy have been utilized in an attempt to eradicate or shrink tumors of the head and neck area in advanced stages to allow subsequent surgical extirpation. Thirty‐six patients (1 stage II; 11 stage III; 24 stage IV; 1 unknown prima